Orphan Drugs 2020: Network pharmacology based repurposed drugs combination for orphan diseases treatment - Daniel Cohen - Pharnext
Charcot-Marie-Tooth type 1a is an orphan genetic progressive dys/demyelinating
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Charcot-Marie-Tooth type 1a is an orphan genetic progressive dys/demyelinating
Background Cold chain management is integral in clinical trials. However, it is
The aims of presentation consist of oncology, diagnostic, different types of cancer
Solid-Phase Extraction (SPE) is a sample clean-up and pre-concentration technique that has been used widely to isolate target analytes from biological samples. Recent trends in SPE techniques ... differs in that all…
Chen et al., 2008). Following stroke, the brain experiences different phases of recuperation where the focal sensory system can revamp neural circuits (neuroplasticity) both spontaneously and with ... bestow extra…
Immune therapy for cancer has started in 1900âÂ?Â?s. However the
The main focus of this current Experimental Thesis Project is the introduction
Anterior cervical decompression and fusion (ACDF) remains the gold standard for subaxial
Here are two main types of vascular lesion in an infant: vascular
The removal of colour, especially from coloured wastewater containing azo dyes has
Children with short intestine syndrome are unable to consume the required nutrients
Background & Aims: Ulcerative colitis (UC) and Crohn’s disease (CD) are Inflammatory
Abstract The nucleus accumbens (NAc) and therefore the ventral tegmental area (VTA
For authors and organisers
Find the right journal for your paper and submit your manuscript.